Detail akcie Tek Life Sc Inv-SBI online

Business Summary: abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of life sciences companies. The Fund invests primarily in securities of public and private companies. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.
Financial Summary: BRIEF: For the six months ended 31 March 2025, abrdn Life Sciences Investors revenues decreased 34% to $1.4M. Net loss totaled $47.2M vs. income of $50.3M. Revenues reflect Dividend income decrease of 30% to $1.1M, Interest and amortization of discount an decrease of 49% to $245K. Net loss reflects Investments in affiliated issuers decrease of 100% to $14K (income), Unrealized G/L on Investment Securitie- decrease of 91% to $393K (income).